Skip to content

A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene

A Prospective Radiostereometric Analysis and Clinical Evaluation of the Zimmer® Continuum® Acetabular Cup With Vitamin E Stabilized Polyethylene

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01754155
Enrollment
55
Registered
2012-12-21
Start date
2013-01-31
Completion date
2018-12-31
Last updated
2017-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiostereometric Analysis, Vitamin E Liner, Zimmer® Continuum® Acetabular Cup

Keywords

Vitamin E, Zimmer, RSA, Radiostereometric Analysis

Brief summary

The purpose of this study is to use Radiostereometric Analysis (RSA) and clinical outcome measures to evaluate early, post-operative implant stability, post-operative implant fixation, clinical performance, and in-vivo wear of the Zimmer® Continuum® Cup with vitamin E stabilized polyethylene.

Interventions

RADIATIONRSA images

All subjects will have the Vitamin E polyethylene and RSA beads placed during surgery. Subjects will then have standard x-ray images and RSA images taken at specific time points up until 2 years post-operatively.

Sponsors

Zimmer Biomet
CollaboratorINDUSTRY
Halifax Biomedical Inc.
CollaboratorINDUSTRY
Central DuPage Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic osteoarthritis of the hip indicating surgical intervention * Scheduled to undergo an uncemented total hip arthroplasty (THA) * Patients between the ages of 18 and 65, inclusive * Ability to give informed consent * Patients will be available for follow-up for a minimum of 2 years after surgery

Exclusion criteria

* Patients less than 18 years of age, or older than 65 years of age. * Post-traumatic arthritis in the affected hip * Rheumatoid arthritis in the affected hip * Hip dysplasia in the affected hip * Prior arthroplasty of the affected hip * Active or prior infection of the affected hip * Morbid obesity (BMI \> 35) * Medical condition precluding major surgery * Severe osteoporosis or osteopenia * Neuromuscular impairment * Patients with known allergy to metals * Pregnancy * Patients with compromised kidney function * Patient is immuno-suppressed * Patients that require a femoral head less than 32 mm or greater than 40mm.

Design outcomes

Primary

MeasureTime frame
Assessing the Continuum® Cup for adequate fixation to the underlying bone as measured by migration and tilt2 years
Assessing the migration pattern of the Continuum® Cup2 years
Determining a correlation between radiolucent lines (RLLs) measured by Charnley-DeLee Zone Analyses and migration characteristics using RSA2 years
Determine if inducible displacement is indicative of adequate fixation2 years
Assess the health status and functional outcome of patients with the Continuum® Cup2 years
Assess the wear rate of the Vitamin E polyethylene with a ceramic femoral head2 years
Determine if the wear rate of the Vitamin E liner is the same in-vivo as it is in simulation testing2 years

Countries

United States

Contacts

Primary ContactStefanie Miller
Stefanie.Miller@CadenceHealth.org630-933-6254
Backup ContactJudy Guerreiro
Judy.Guerreiro@CadenceHealth.org630-933-2941

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026